Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 28, 2017 - Issue 4
Submit an article Journal homepage
1,355
Views
7
CrossRef citations to date
0
Altmetric
Atopic Dermatitis & Itch

Dermatologic uses of omalizumabFootnote*

Justin C. ChiaDivision of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, CanadaCorrespondence[email protected]
&
P. Régine MydlarskiDivision of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada
Pages 332-337 | Received 15 Sep 2016, Accepted 03 Oct 2016, Published online: 07 Nov 2016

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jonathan A. Bernstein, Abhishek Kavati, Michael D. Tharp, Benjamin Ortiz, Karen MacDonald, Kris Denhaerynck & Ivo Abraham. (2018) Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence. Expert Opinion on Biological Therapy 18:4, pages 425-448.
Read now

Articles from other publishers (6)

Xiaoya Ling, Xinyang Shou, Yufei Lou, Jie Ling, Mengyuan Zhang, Tugen Yu & Weijia Gu. (2023) Research progress of omalizumab in the treatment of bullous pemphigoid. The Journal of Dermatology 50:5, pages 575-587.
Crossref
Funda Kemeriz, Emine Müge Acar & Melike Ordu. (2020) Omalizumab induced lichenoid drug eruption triggered by sun exposure. Dermatologic Therapy 33:4.
Crossref
Benoit Brilland, Marc Scherlinger, Liliane Khoryati, Julien Goret, Pierre Duffau, Estibaliz Lazaro, Manon Charrier, Vivien Guillotin, Christophe Richez & Patrick Blanco. (2019) Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus. Clinical Reviews in Allergy & Immunology 58:2, pages 194-212.
Crossref
Cesar Daniel Alonso-Bello, María del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño, Sagrario Hierro-Orozco, Mario Alberto Ynga-Durand, Laura Berrón-Ruiz, Julio César Alcántara-Montiel, Leopoldo Santos-Argumedo, Diana Andrea Herrera-Sánchez, Fernando Lozano-Patiño & María Isabel Castrejón-Vázquez. (2019) Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome. Case Reports in Immunology 2019, pages 1-5.
Crossref
L. Solman, A. Lloyd‐Lavery, D. J. C. Grindlay, N. K. Rogers, K. S. Thomas & K. E. Harman. (2019) What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention. Clinical and Experimental Dermatology 44:4, pages 363-369.
Crossref
Ece Nur Degirmentepe, Kubra Kızıltac, Pırıl Etikan, Ralfi Singer, Bachar Memet & Emek Kocaturk. (2019) Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature. Annals of Dermatology 31:3, pages 335.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.